MESO
Income statement / Annual
Last year (2024), Mesoblast Limited's total revenue was $5.90 M,
a decrease of 21.32% from the previous year.
In 2024, Mesoblast Limited's net income was -$87.96 M.
See Mesoblast Limited’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$5.90 M
|
$7.50 M
|
$10.21 M
|
$7.46 M
|
$32.16 M
|
$16.72 M
|
$17.34 M
|
$2.41 M
|
$42.55 M
|
$23.75 M
|
Cost of Revenue |
$15.72 M |
$27.73 M |
$30.76 M |
$32.72 M |
$25.31 M |
$15.36 M |
$5.51 M |
$12.07 M |
$29.76 M |
$23.78 M |
Gross Profit |
-$9.82 M |
-$20.23 M |
-$20.55 M |
-$25.26 M |
$6.85 M |
$1.36 M |
$11.83 M |
-$9.65 M |
$12.79 M |
-$35,000.00 |
Gross Profit Ratio |
-1.66 |
-2.7 |
-2.01 |
-3.39 |
0.21 |
0.08 |
0.68 |
-4 |
0.3 |
-0 |
Research and Development
Expenses |
$25.35 M
|
$27.19 M
|
$32.82 M
|
$53.01 M
|
$56.19 M
|
$59.82 M
|
$65.93 M
|
$58.91 M
|
$50.01 M
|
$77.59 M
|
General & Administrative
Expenses |
$23.63 M
|
$25.37 M
|
$27.21 M
|
$30.87 M
|
$25.61 M
|
$21.63 M
|
$21.91 M
|
$23.01 M
|
$22.50 M
|
$36.17 M
|
Selling & Marketing
Expenses |
$15.72 M
|
$27.73 M
|
$30.76 M
|
$32.72 M
|
$25.31 M
|
$15.36 M
|
$5.51 M
|
$12.07 M
|
$29.76 M
|
$29.21 M
|
Selling, General &
Administrative Expenses |
$23.63 M
|
$53.11 M
|
$57.97 M
|
$63.59 M
|
$50.92 M
|
$36.98 M
|
$27.42 M
|
$35.07 M
|
$52.26 M
|
$65.38 M
|
Other Expenses |
-$37,000.00 |
$0.00 |
$3,000.00 |
-$1.54 M |
$455,000.00 |
$1.09 M |
-$1.15 M |
$0.00 |
$0.00 |
$122,000.00 |
Operating Expenses |
$48.98 M |
$76.79 M |
$90.79 M |
$115.06 M |
$107.56 M |
$97.88 M |
$92.03 M |
$92.50 M |
$98.44 M |
$137.14 M |
Cost And Expenses |
$64.70 M |
$76.79 M |
$90.79 M |
$115.06 M |
$107.56 M |
$97.88 M |
$92.03 M |
$92.50 M |
$98.44 M |
$137.14 M |
Interest Income |
$1.82 M |
$831,000.00 |
$3,000.00 |
$22,000.00 |
$542,000.00 |
$719,000.00 |
$366,000.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$20.66 M |
$19.44 M |
$16.91 M |
$10.71 M |
$13.33 M |
$11.33 M |
$1.83 M |
$0.00 |
$9.31 M |
$10.53 M |
Depreciation &
Amortization |
$4.67 M
|
$4.11 M
|
$4.38 M
|
$4.26 M
|
$3.67 M
|
$2.14 M
|
$2.65 M
|
$3.06 M
|
$2.19 M
|
$1.96 M
|
EBITDA |
-$51.48 M
|
-$65.03 M
|
-$76.57 M
|
-$107.60 M
|
-$75.41 M
|
-$81.16 M
|
-$74.69 M
|
-$89.96 M
|
-$28.07 M
|
-$115.87 M
|
EBITDA Ratio |
-8.72 |
-8.67 |
-7.5 |
-14.43 |
-2.34 |
-4.85 |
-4.31 |
-37.29 |
-0.66 |
-4.88 |
Operating Income Ratio
|
-9.96
|
-9.22
|
-7.93
|
-15
|
-2.46
|
-4.98
|
-4.34
|
-37.33
|
-1.31
|
-4.77
|
Total Other
Income/Expenses Net |
-$29.35 M
|
$6.48 M
|
-$10.63 M
|
$12.24 M
|
-$8.28 M
|
-$15.45 M
|
$10.54 M
|
-$130,000.00
|
-$25.62 M
|
$4.55 M
|
Income Before Tax |
-$88.15 M |
-$82.10 M |
-$91.59 M |
-$99.63 M |
-$87.36 M |
-$98.75 M |
-$65.98 M |
-$90.22 M |
-$90.82 M |
-$119.37 M |
Income Before Tax Ratio
|
-14.94
|
-10.95
|
-8.97
|
-13.36
|
-2.72
|
-5.91
|
-3.8
|
-37.4
|
-2.13
|
-5.03
|
Income Tax Expense |
-$191,000.00 |
-$212,000.00 |
-$239,000.00 |
-$819,000.00 |
-$9.42 M |
-$8.96 M |
-$30.69 M |
-$13.40 M |
-$86.69 M |
$6.10 M |
Net Income |
-$87.96 M |
-$81.89 M |
-$91.35 M |
-$98.81 M |
-$77.94 M |
-$89.80 M |
-$35.29 M |
-$76.82 M |
-$4.13 M |
-$119.37 M |
Net Income Ratio |
-14.9 |
-10.92 |
-8.95 |
-13.25 |
-2.42 |
-5.37 |
-2.04 |
-31.85 |
-0.1 |
-5.03 |
EPS |
-0.89 |
-1.05 |
-1.33 |
-1.55 |
-1.4 |
-1.72 |
-0.38 |
-0.96 |
-0.0567 |
-1.84 |
EPS Diluted |
-0.89 |
-1.05 |
-1.33 |
-1.55 |
-1.4 |
-1.72 |
-0.38 |
-0.96 |
-0.0567 |
-1.84 |
Weighted Average Shares
Out |
$98.67 M
|
$77.95 M
|
$68.44 M
|
$63.82 M
|
$55.77 M
|
$52.14 M
|
$93.14 M
|
$79.81 M
|
$72.84 M
|
$64.82 M
|
Weighted Average Shares
Out Diluted |
$98.67 M
|
$77.95 M
|
$68.44 M
|
$63.82 M
|
$55.77 M
|
$52.14 M
|
$93.14 M
|
$79.87 M
|
$72.84 M
|
$64.82 M
|
Link |
|
|
|
|
|
|
|
|
|
|